Creating a synthetic version of the Ebola virus to help fight the real thing

ebola exlarge

Scientists at the Centers from Disease Control and Prevention have created a synthetic version of the Ebola virus circulating in the Democratic Republic of the Congo, part of an effort to determine whether diagnostic tests and experimental treatments being used in the field are effective.

The research, conducted in the agency’s most secure laboratories — BSL4 — showed that even though the tests and two of the treatments being used in the field were developed based on earlier variation of Ebola viruses, they continue to be effective against the virus causing the current outbreak.

Ebola scientists who were not involved in the work praised the CDC’s effort, saying it is important to test the tools being used against the virus in the outbreak. But they noted it would be easier, faster, and potentially more accurate to use actual viruses.


Gary Kobinger, who led the work to develop the Ebola treatment ZMapp — one of the therapies the CDC group tested against the synthesized virus — said it is becoming increasingly difficult to get pathogens to study. It’s a global trend, he said, and one that threatens the world’s ability to conduct surveillance and develop diagnostic tests for disease-causing pathogens.

Read full, original post: CDC made a synthetic Ebola virus to test treatments. It worked

Related article:  How we are developing a coronavirus vaccine so quickly
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend